Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.
企業コードMGRX
会社名Mangoceuticals Inc
上場日Mar 21, 2023
最高経営責任者「CEO」Cohen (Jacob D)
従業員数- -
証券種類Ordinary Share
決算期末Mar 21
本社所在地15110 Dallas Pkwy, Suite 600
都市DALLAS
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号75248
電話番号18336264679
ウェブサイトhttps://www.mangorx.com/
企業コードMGRX
上場日Mar 21, 2023
最高経営責任者「CEO」Cohen (Jacob D)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし